Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease

Fleur Schaper, Peter Heeringa, Marc Bijl, Johanna Westra
2013 Current Opinion in Rheumatology  
doi:10.1097/bor.0b013e32835cee2d pmid:23249831 fatcat:kil3pi7pwjhlhauaoifivgse54